GE HealthCare (Nasdaq: GEHC) announced today that it received FDA 510(k) clearance and CE mark for its Allia Moveo platform.
New collaboration seeks to advance precision care through intuitive visualization, remote collaboration and evidence-based insights. “We are thrilled to advance our strategic collaboration with GE ...
Compact, cable-free C-arm aims to maximize space and movement and allow greater flexibility and accessibility for everyday performance Patient-centric design featuring lateral wide-bore cone beam ...
GE HealthCare Technologies Inc. GEHC recently announced that it has obtained FDA 510(k) clearance and CE Marking for its ...
CHICAGO--(BUSINESS WIRE)--GE HealthCare (Nasdaq: GEHC) announced today the 510(k) submission to the U.S. Food and Drug Administration for CleaRecon DL, deep learning technology, designed to improve ...
CleaRecon DL receives 510(k) clearance and CE mark, paving the way for clinicians to use 3D image guidance technologies to their full potential with the goal of achieving better clinical and ...
First worldwide Allia Moveo installation at Hôpital Marie-Lannelongue in France highlights progress in redefining interventional care deliveryAllia Moveo combines mobility, versatility and AI-powered ...